Article: Investigators at Eulji University School of Medicine, Department of Family Medicine zero in on bone research.(Report)

Research findings, 'Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss,' are discussed in a new report. "High bone turnover, with bone resorption exceeding bone formation, is a major mechanism of postmenopausal osteoporosis. Therefore, inhibition of bone resorption is a rational approach for the prevention of bone loss," investigators in Korea report (see also Bone Research).

"The objective of the current study was to determine the short-term efficacy of once-weekly low-dose alendronate in the prevention of bone loss, via bone turnover markers, in early postmenopausal Korean women with moderate bone ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!